Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort (2024) de Castro T, Welland S, Jochheim L, Leyh C, Shmanko K, Finkelmeier F, Jeliazkova P, et al. Journal article The tyrosine kinase Yes1 is a druggable host factor of HEV (2024) Haase JA, Baheerathan A, Zhang X, Fu RM, Nocke MK, Decker C, Dao Thi VL, et al. Journal article Risk factors for cardiovascular disease among individuals with hepatic steatosis (2022) Karady J, Ferencik M, Mayrhofer T, Meyersohn NM, Bittner DO, Staziaki P, Szilveszter B, et al. Journal article Deficient IL-6/Stat3 Signaling, High TLR7, and Type I Interferons in Early Human Alcoholic Liver Disease: A Triad for Liver Damage and Fibrosis (2019) Starkel P, Schnabl B, Leclercq S, Komuta M, Bataller R, Argemi J, Palma E, et al. Journal article Can genetic testing guide the therapy of cholestatic pruritus? A case of benign recurrent intrahepatic cholestasis type 2 with severe nasobiliary drainage-refractory itch (2018) Holz R, Kremer A, Luetjohann D, Wasmuth HE, Lammert F, Krawczyk M Journal article